AngalBio
Latest round
- Series A
Last raised
- Apr 2026
Total raised
- Undisclosed
Investors
- 1
About AngalBio
, trading under the name AngalBio, focuses on biopharmaceutical research and development. The company works with research institutions and healthcare partners to develop biopharmaceutical therapies. Its pipeline includes antisense oligonucleotide candidates targeting specific genetic markers, with applications in diseases such as glioblastoma. The company also engages in licensing and technology transfer collaborations to advance drug development programs. The company generates revenue through licensing agreements and partnerships, including upfront payments and milestone-based royalties linked to the development and commercialization of its drug candidates.
Who invested in AngalBio
1 investor across 1 round
See all investors in AngalBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 29, 2026
Amount
Undisclosed
Investors
Questions about AngalBio
Who invested in AngalBio?
AngalBio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AngalBio raised?
AngalBio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AngalBio last raise money?
AngalBio's most recent round on record is a Series A, in Apr 2026.
What does AngalBio do?
, trading under the name AngalBio, focuses on biopharmaceutical research and development.
Where is AngalBio headquartered?
AngalBio is headquartered in Suzhou, China.
Which VCs invest in companies like AngalBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at AngalBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like AngalBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.